Gil, Jesús
Article History
First Online: 8 April 2019
Competing interests
: J.G. owns equity and is a consultant for Unity Biotechnology. Unity Biotechnology funds research on senolytics in J.G.’s laboratory. J.G is a named inventor in a filed MRC patent related to senolytic therapies (PCT/GB2018/051437) that has been licensed to Unity Biotechnology.
Free to read: This content has been made available to all.